position: EnglishChannel > Sci-Tech News > Article

Coronavirus vaccine race should put saving lives first

Source: International Communication Center for Science & Technology| 2020-05-06 17:18:13| Author: Lu Zijian, Fang Linlin & China.org

太阳城申博88登入,在格局方面,雷军的关注点更多的是在产品能否让用户满意,而不是企业的盈利能力。  2015年2月27日,习近平在中央深改组第十次会议上强调  人民有所呼、改革有所应  必须从贯彻落实四个全面战略布局的高度,深刻把握全面深化改革的关键地位和重要作用,拿出勇气和魄力,自觉运用改革思维谋划和推动工作,不断提高领导、谋划、推动、落实改革的能力和水平,切实做到人民有所呼、改革有所应。2000年底,原铁道部出资103亿元注册成立了铁通公司。然而,在其刚上市后不久,便被曝出其电池发生自燃,危级全球多位用户。

这是决定文化性质和方向的最深层次要素。“如果没有完善的线下销售、服务体系,线上营销会遇到种种难以解决的问题。  广告提示:赞助商提供内容仅供阅读,不构成投资建议,请谨慎对待。“酷派的变革是从品牌开始的,这次发布的锋尚MAX,就非常符合我们品牌的定位,它是第一款按照品牌定位做出的产品。


A worker of CNBG is testing the illuminance in the workshop where the inactivated vaccine is being tested.(Photo by Zhang Yuwei, Xinhua News)


Wall Street Journal published an opinion article on April 27 stating that, while China's vaccine development is making rapid progress, "America needs to win the coronavirus vaccine race."

The vaccine is considered the most powerful weapon to defeat the coronavirus. Scientists worldwide are racing against time to develop the vaccine.

On March 16, the U.S. announced that a nucleic acid vaccine began clinical trials. On the same day, Chen Wei, a top epidemiologist and virologist with China's Academy of Military Medical Sciences, was authorized to start a clinical trial with an adenovirus vector vaccine, and injected it into the body of a volunteer for the first time. At the end of March, Israel announced breakthroughs in developing vaccines and will soon begin animal testing. In early April, U.S. researchers carried out a patch vaccine test in animals. On April 28, the fourth vaccine in China officially went into clinical trials.

The race to develop the vaccine raised concerns of the WSJ article's author, former U.S. FDA commissioner Scott Gottlieb. He wrote that the FDA should cooperate with corporations to begin safety tests at the early stage to save time, while carrying out vaccine assessment and animal tests in the laboratory at the same time. The article said the first nation to develop a vaccine for COVID-19 could have an economic advantage, and thus will be the first to restore its economy and global influence.

I think the article's perspective of “whoever gets the vaccine gets the world” stands at a low position.

The pandemic is spreading worldwide, and has become a global issue beyond a specific country or region. Countries around the world should work together to push for the development of vaccines and let them benefit the whole world. The success in developing vaccines should not be narrowly connected with national competition and economic recovery.

China is a forerunner in developing the vaccine, which relies on its strong leadership and solidarity in the fight against the virus.

With coordinated efforts by scientific researchers in different sectors, China has promoted information sharing and joint experiments, moving the development of multiple vaccines toward a new stage. At the same time, companies specialized in vaccine R&D also played a part. In the early stage of the outbreak in China, China CDC reached a consensus with some corporations on joint efforts to invest in vaccine R&D, which ensured large-scale productivity of vaccines at a later time. Moreover, many volunteers have also taken part in clinical trials, thus providing ample samples for vaccine R&D, and helping to reduce errors.

China has always upheld the concept of international cooperation, which won recognition from the WHO and the international scientific community.

When a seminar on global research and innovation on COVID-19 was held in early February, the WHO called on the international community to join the formulation of the "scientific research roadmap" for COVID-19, so as to promote the process of diagnosis, treatment, and vaccine development. In mid-April, an expert group made up of more than 120 scientists, physicians, sponsors, and manufacturers from around the world publicly announced that they are committed to joining efforts to speed up the development of vaccines under the WHO coordination.

China has always stuck to the concept of building the community of a shared future for mankind, which is also practiced by Chinese scientists when they are endeavoring to develop the vaccine. No matter which country wins the race, the country should shoulder the responsibility of getting people's life back on track. Tracing the origin and saving lives are the real motivation behind the development, and also the original aspiration and mission for the global scientific community to move forward together.

(You can also read this at: 太阳城申博88登入/www_china_org_cn/china/special_coverage/2020-05/06/content_76011049.htm)

Editor:Lu Zijian

Top News

  • On May 22, Ms.Beate Trankmann, UNDP(United Nations Development Programme)Resident Representative in China, was interviewed by mail. During the interview, Ms.Beate Trankmann responded to three questions around the contribution that China has made for the 2030 Agenda for Sustainable Development through its achievement in poverty reduction.

Israel-China Innovation Cooperation Benefits All

China is a model for making its vision to lead global innovation.China leads the development of infrastructure for an advanced technological environment, and the number of its people’s use of technologies and applications increases every year. In many fields, China is also a role model for global innovation.

A Future to Expect: International S&T Community Expresses High Hope in Cooperation with Peers in China English

According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

ICGEB Accepted 20,000 Protective Face Masks Donation from Chinese Partners

The ICGEB in Trieste, Italy has received a consignment of protective masks from its Chinese partners in Beijing and Taizhou, for distribution?to the local health authorities.

Copyright ? Science and Technology Daily, All Rights Reserved

mailto: yuhy@太阳城申博88登入 www.yinhe618.com

菲律宾太阳网a99.com 菲律宾申博代理登录 申博游戏下载官方登入 太阳城在线注册登入 申博官网开户登入 www.11sbc.com
旧版太阳城直营网 菲律宾太阳城申博88msc登入 太阳城申博娱乐官网直营网 申博代理登录 菲律宾太阳网娱乐登入 菲律宾申博游戏怎么登入
申博代理直营网 申博游戏苹果手机能玩吗 申博注册账户登入 申博登录不了 www.662588.com 菲律宾太阳娱乐登入官网